Rat TNF-alpha FlowCytomix Simplex

Also known as: Cachectin, Tumor necrosis factor alpha, DIF

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# BMS8622FF*

Cat. No. Size
BMS8622FF 96 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Rat TNF-alpha FlowCytomix Simplex.

Click on image to view more information.

  • Data for Rat TNF-alpha FlowCytomix Simplex.
Description

Description: This FlowCytomix Simplex Kit is designed for the measurement of Rat TNF-alpha in an immunoassay analyzed on a flow cytometer. Together with the FlowCytomix Mouse/Rat Basic Kit (cat. BMS8440FF), this kit can be used to detect TNF-alpha alone or can be multiplexed with other Simplex Kits to measure a variety of analytes.

This kit contains bead population A12.

Tumor Necrosis Factor alpha (TNF-alpha), also known as cachectin, is a polypeptide cytokine produced by monocytes and macrophages. It functions as a multipotent modulator of immune response and further acts as a potent pyrogen. TNF-alpha circulates throughout the body responding to stimuli (infectious agents or tissue injury), activating neutrophils, altering the properties of vascular endothelial cells, regulating metabolic activities of other tissues, as well as exhibiting tumoricidal activity by inducing localized blood clotting. TNF-alpha also inhibits lipoprotein lipase activity resulting in cachexia, a physical wasting condition. Due to its varied actions throughout the immune system, TNF-alpha may play a role in the pathogenesis of many disease states.

TNF-alpha production is mediated by the action of lymphokines and endotoxins on the macrophage. Purified monocytes produce TNF-alpha within four hours of stimulation by recombinant IL-2 and there is some in vitro evidence to suggest that TNF-alpha is expressed at high levels and with prolonged kinetics in T cells stimulated by both CD2 and CD28. Secretion of TNF-alpha is enhanced by gamma interferon. TNF then induces or enhances the specific production of Class I MHC antigen, GM-CSF, and IL-1. Recent evidence has suggested an intracellular role for this peptide.

Details
Reactivity Rat
Sample Volume 25 uL
Suitable Sample Types cell culture supernatant, serum, plasma (heparin)
Sensitivity 4.3 pg/mL
Standard Curve Range 27 - 20,000 pg/mL
Components 1 vial (175 ul) Fluorescent Beads (20x) coated with polyclonal antibody to rat TNF-alpha, Bead Population A12
2 vials rat TNF-alpha Standard (lyophilized): 400 ng/ml upon reconstitution
1 vial (350 ul) Biotin-Conjugate (20x) anti-rat TNF-alpha polyclonal antibody
Reported Applications Multiplex Immunoassay
Documentation
TDS Link Download TDS
Related Products
Cat. No. Name Excite Emit Application Reg.
85-86081 NFkB p65 (Total) InstantOne™ ELISA ELISA RUO
BMS621* Rat IFN-gamma Platinum ELISA ELISA RUO
BMS633* Rat GM-CSF Platinum ELISA ELISA RUO
BMS634* Rat IL-2 Platinum ELISA ELISA RUO
References

Citations: Young,Shih-Houng; Antonini,James M.; Roberts,Jenny R.; Erdely,Aaron D.; Zeidler-Erdely,Patti C.. Performance evaluation of cytometric bead assays for the measurement of lung cytokines in two rodent models. Journal of Immunological Methods 2008;331:59-68. (Link)

References: Kawane,K.; Ohtani,M.; Miwa,K.; Kizawa,T.; Kanbara,Y.; Yoshioka,Y.; Yoshikawa,H.; Nagata,S.. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 2006;443:998-1002. (Link)

Aggarwal,B.B.; Shishodia,S.; Takada,Y.; Jackson-Bernitsas,D.; Ahn,K.S.; Sethi,G.; Ichikawa,H.. TNF blockade: an inflammatory issue. Ernst.Schering.Res Found.Workshop 2006;161-186. (Link)

Pfeffer,K.. Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev. 2003;14:185-191. (Link)

McGuire,W.; Hill,A.V.; Allsopp,C.E.; Greenwood,B.M.; Kwiatkowski,D.. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-510. (Link)

Moehle,C.; Ackermann,N.; Langmann,T.; Aslanidis,C.; Kel,A.; Kel-Margoulis,O.; Schmitz-Madry,A.; Zahn,A.; Stremmel,W.; Schmitz,G.. Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease. J Mol Med 2006;84:1055-1066. (Link)

McLaughlin,P.J.; Aikawa,A.; Davies,H.M.; Ward,R.G.; Bakran,A.; Sells,R.A.; Johnson,P.M.. Evaluation of sequential plasma and urinary tumor necrosis factor alpha levels in renal allograft recipients. Transplantation 1991;51:1225-1229. (Link)

Aringer,M.; Smolen,J.S.. The role of tumor necrosis factor-alpha in systemic lupus erythematosus. Arthritis Res Ther 2008;10:202(Link)

Aggarwal,B.B.. Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB. Ann Rheum Dis 2000;59 Suppl 1:i6-16. (Link)

Davis,J.C.,Jr.; Mease,P.J.. Insights into the pathology and treatment of spondyloarthritis: from the bench to the clinic. Semin.Arthritis Rheum 2008;38:83-100. (Link)

Al-Aly,Z.. Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy. Transl.Res 2008;151:233-239. (Link)

Holler,E.; Kolb,H.J.; Moller,A.; Kempeni,J.; Liesenfeld,S.; Pechumer,H.; Lehmacher,W.; Ruckdeschel,G.; Gleixner,B.; Riedner,C.; .. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 1990;75:1011-1016. (Link)

Mukhopadhyay,S.; Hoidal,J.R.; Mukherjee,T.K.. Role of TNFalpha in pulmonary pathophysiology. Respir.Res 2006;7:125(Link)

Lorenzo,M.; Fernandez-Veledo,S.; Vila-Bedmar,R.; Garcia-Guerra,L.; De,Alvaro C.; Nieto-Vazquez,I.. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes. J Anim Sci. 2008;86:E94-104. (Link)

Aggarwal,B.B.. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev.Immunol 2003;3:745-756. (Link)

Beutler,B.; Bazzoni,F.. TNF, apoptosis and autoimmunity: a common thread?. Blood Cells Mol Dis 1998;24:216-230. (Link)

Pietrzak,A.T.; Zalewska,A.; Chodorowska,G.; Krasowska,D.; Michalak-Stoma,A.; Nockowski,P.; Osemlak,P.; Paszkowski,T.; Rolinski,J.M.. Cytokines and anticytokines in psoriasis. Clin Chim.Acta 2008;394:7-21. (Link)

Wong,M.; Ziring,D.; Korin,Y.; Desai,S.; Kim,S.; Lin,J.; Gjertson,D.; Braun,J.; Reed,E.; Singh,R.R.. TNFalpha blockade in human diseases: mechanisms and future directions. Clin Immunol 2008;126:121-136. (Link)

Mocellin,S.; Rossi,C.R.; Pilati,P.; Nitti,D.. Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev. 2005;16:35-53. (Link)

Lin,J.; Ziring,D.; Desai,S.; Kim,S.; Wong,M.; Korin,Y.; Braun,J.; Reed,E.; Gjertson,D.; Singh,R.R.. TNFalpha blockade in human diseases: an overview of efficacy and safety. Clin Immunol 2008;126:13-30. (Link)

Tilg,H.; Moschen,A.R.. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 2008;14:222-231. (Link)

Gaur,U.; Aggarwal,B.B.. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem.Pharmacol 2003;66:1403-1408. (Link)

Nichols,D.; Chmiel,J.; Berger,M.. Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling. Clin Rev.Allergy Immunol 2008;34:146-162. (Link)

Varfolomeev,E.E.; Ashkenazi,A.. Tumor necrosis factor: an apoptosis JuNKie?. Cell 2004;116:491-497. (Link)

Norman,R.A.; Bogardus,C.; Ravussin,E.. Linkage between obesity and a marker near the tumor necrosis factor-alpha locus in Pima Indians. J Clin Invest 1995;96:158-162. (Link)

Morgan,M.J.; Kim,Y.S.; Liu,Z.G.. TNFalpha and reactive oxygen species in necrotic cell death. Cell Res 2008;18:343-349. (Link)